Lenacapavir Plus bNAbs for People with HIV and Sensitivity to either Teropavimab or Zinlirvimab

Category Primary study
ConferenceBHIVA Spring Conference 2024
Year 2024
This article has no abstract
Epistemonikos ID: 019b2bc3d5cb5ba37818620f5189f1707ef7dfe5
First added on: Dec 16, 2025